Clinical Findings of COVID-19 Patients Admitted to Intensive Care Units in Guangdong Province, China: A Multicenter, Retrospective, Observational Study.
Clinical Findings of COVID-19 Patients Admitted to Intensive Care Units in Guangdong Province, China: A Multicenter, Retrospective, Observational Study.
复制标题
DOI:
10.3389/fmed.2020.576457
复制
发表时间:
2020
影响因子:
3.9
通讯作者:
Li Y
中科院分区:
文献类型:
--
作者:
Xu Y;Xu Z;Liu X;Cai L;Zheng H;Huang Y;Zhou L;Huang L;Ling Y;Deng L;Li J;Chen S;Liu D;Lin Z;Zhou L;He W;Zhong N;Liu X;Li Y
Background: Information about critically ill patients with coronavirus disease 2019 (COVID-19) in China but outside of Wuhan is scarce. We aimed to describe the clinical features, treatment, and outcomes of patients with COVID-19 admitted to the intensive care unit (ICU) in Guangdong Province. Methods: In this multicenter, retrospective, observational study, we enrolled consecutive patients with COVID-19 who were admitted to seven ICUs in Guangdong Province. Demographic data, symptoms, laboratory findings, comorbidities, treatment, and outcomes were collected. Data were compared between patients with and without intubation. Results: A total of 45 COVID-19 patients required ICU admission in the study hospitals [mean age 56.7 ± 15.4 years, 29 males (64.4%)]. The most common symptoms at onset were fever and cough. Most patients presented with lymphopenia and elevated lactate dehydrogenase. Treatment with antiviral drugs was initiated in all patients. Thirty-six patients (80%) developed acute respiratory distress syndrome at ICU admission, and 15 (33.3%) septic shock. Twenty patients (44.4%) were intubated, and 10 (22.2%) received extracorporeal membrane oxygenation. The 60-day mortality was 4.4% (2 of 45). Conclusion: COVID-19 patients admitted to ICU were characterized by fever, lymphopenia, acute respiratory failure, and multiple organ dysfunction. The mortality of ICU patients in Guangdong Province was relatively low with a small sample size.
登录
查看更多内容
DOI:
10.1186/cc11454
发表时间:
2013-02-04
期刊:
Critical care (London, England)
影响因子:
--
作者:
Kellum JA;Lameire N;KDIGO AKI Guideline Work Group
通讯作者:
KDIGO AKI Guideline Work Group
影响因子:
3.4
作者:
Wang, Jiajia;Xu, Hua;Yang, Xinjing;Zhao, Daguo;Liu, Shenglan;Sun, Xue;Huang, Jian-an;Guo, Qiang
通讯作者:
Guo, Qiang
影响因子:
5.2
作者:
Guo, Lingxi;Wei, Dong;Qu, Jieming
通讯作者:
Qu, Jieming
影响因子:
20.6
作者:
Tang, Xiaolu;Wu, Changcheng;Lu, Jian
通讯作者:
Lu, Jian
DOI:
10.2169/internalmedicine.0316-17
发表时间:
2018-07-01
期刊:
Internal medicine (Tokyo, Japan)
影响因子:
--
作者:
Ito T;Akamatsu K;Ukimura A;Fujisaka T;Ozeki M;Kanzaki Y;Ishizaka N
通讯作者:
Ishizaka N